Alexion Pharma names former Baxalta head Ludwig Hantson CEO

March 27 (Reuters) - Alexion Pharmaceuticals Inc said it named former Baxalta head Ludwig Hantson chief executive officer as the rare-disease drug maker looks to steady the ship following the exit of its top management.